[go: up one dir, main page]

LT3558381T - Skysta žmogaus fibrinogeno kompozicija - Google Patents

Skysta žmogaus fibrinogeno kompozicija

Info

Publication number
LT3558381T
LT3558381T LTEP17837979.8T LT17837979T LT3558381T LT 3558381 T LT3558381 T LT 3558381T LT 17837979 T LT17837979 T LT 17837979T LT 3558381 T LT3558381 T LT 3558381T
Authority
LT
Lithuania
Prior art keywords
human fibrinogen
liquid human
fibrinogen composition
composition
liquid
Prior art date
Application number
LTEP17837979.8T
Other languages
English (en)
Inventor
Clémence DEBRAIZE
Original Assignee
Laboratoire Français Du Fractionnement Et Des Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Français Du Fractionnement Et Des Biotechnologies filed Critical Laboratoire Français Du Fractionnement Et Des Biotechnologies
Publication of LT3558381T publication Critical patent/LT3558381T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LTEP17837979.8T 2016-12-22 2017-12-22 Skysta žmogaus fibrinogeno kompozicija LT3558381T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1663181A FR3061020B1 (fr) 2016-12-22 2016-12-22 Composition de fibrinogene humain
PCT/FR2017/053839 WO2018115800A1 (fr) 2016-12-22 2017-12-22 Composition liquide de fibrinogene humain

Publications (1)

Publication Number Publication Date
LT3558381T true LT3558381T (lt) 2021-08-10

Family

ID=58358663

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17837979.8T LT3558381T (lt) 2016-12-22 2017-12-22 Skysta žmogaus fibrinogeno kompozicija

Country Status (17)

Country Link
US (1) US20200093896A1 (lt)
EP (1) EP3558381B1 (lt)
CN (2) CN110087689B (lt)
CY (1) CY1124609T1 (lt)
DK (1) DK3558381T3 (lt)
ES (1) ES2877848T3 (lt)
FR (1) FR3061020B1 (lt)
HR (1) HRP20210984T1 (lt)
HU (1) HUE055246T2 (lt)
LT (1) LT3558381T (lt)
MX (2) MX2019007608A (lt)
PL (1) PL3558381T3 (lt)
PT (1) PT3558381T (lt)
RS (1) RS62103B1 (lt)
SI (1) SI3558381T1 (lt)
SM (1) SMT202100369T1 (lt)
WO (1) WO2018115800A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12030918B2 (en) * 2019-12-06 2024-07-09 University Of Wyoming Fibrin particles and methods of forming fibrin particles
KR20240044450A (ko) 2021-08-13 2024-04-04 바이오테스트 아게 피브리노겐 조성물 및 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE336207C (de) 1916-03-05 1921-04-28 Siemens & Halske Akt Ges Vermittlungsvorrichtung fuer Fernsprechleitungen
DE69930653T2 (de) 1998-09-24 2007-01-25 Pharming Intellectual Property Bv Reinigung von fibrinogen aus milch durch den einsatz von kationenaustauschchromatographie
ES2267289T3 (es) 1998-09-24 2007-03-01 Pharming Intellectual Property Bv Purificacion de fibrinogeno a partir de fluidos mediante precipitacion y cromatografia de interaccion hidrofoba.
DE10261126A1 (de) * 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CA2682173C (en) * 2007-03-22 2015-10-27 Shinichi Miyagawa Solid fibrinogen preparation
EP2987498B1 (en) * 2008-05-02 2017-07-05 Laboratoire Français du Fractionnement et des Biotechnologies Treatment of bleeding with low half-life fibrinogen
CN101371921B (zh) * 2008-10-08 2013-02-13 余美伦 一种速溶冻干纤维蛋白原和凝血酶制剂组合物、制备方法及其用途
CN102286095B (zh) * 2011-07-06 2013-08-21 大田华灿生物科技有限公司 纤维蛋白原的制备方法
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines

Also Published As

Publication number Publication date
CN110087689B (zh) 2023-09-29
MX2019007608A (es) 2019-08-29
FR3061020B1 (fr) 2019-05-17
FR3061020A1 (fr) 2018-06-29
DK3558381T3 (da) 2021-06-28
CN117180406A (zh) 2023-12-08
RS62103B1 (sr) 2021-08-31
SMT202100369T1 (it) 2021-09-14
HUE055246T2 (hu) 2021-11-29
CN110087689A (zh) 2019-08-02
WO2018115800A1 (fr) 2018-06-28
PT3558381T (pt) 2021-07-01
HRP20210984T1 (hr) 2021-09-17
PL3558381T3 (pl) 2021-10-25
ES2877848T3 (es) 2021-11-17
SI3558381T1 (sl) 2021-11-30
CY1124609T1 (el) 2022-07-22
EP3558381A1 (fr) 2019-10-30
MX2021001361A (es) 2021-04-13
EP3558381B1 (fr) 2021-04-07
US20200093896A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
IL248519A0 (en) Bioceramic compositions and biomodulatory uses thereof
EP3334590A4 (en) CLEANING COMPOSITION
BR112016026879A2 (pt) Composição farmacêutica líquida
DK3416996T3 (da) Hærdelig sammensætning
DK3532029T3 (da) Flydende farmaceutisk sammensætning
DK3558278T3 (da) Flydende cannabinoidsammensætning
DK3496551T3 (da) Flydende allulosesammensætning
EP3415008A4 (en) GERMIC COMPOSITION
KR20180084853A (ko) 지혈 조성물
EP3395325A4 (en) LIQUID COSMETIC COMPOSITION
DK3528902T3 (da) Ringegelsammensætning
EP3530711A4 (en) GEL COMPOSITION
EP3556804A4 (en) COMPOSITION
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
EP3610850A4 (en) COMPOSITION OF SKIN CLEANSING AGENT
EP3443034C0 (en) COMPOSITION
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
EP3610847A4 (en) COMPOSITION OF SKIN CLEANSING AGENT
EP3561030A4 (en) FAT COMPOSITION
EP3539532A4 (en) SKIN CARE COMPOSITION
EP3524627A4 (en) COMPOSITION
EP3521505A4 (en) Composition
PL3481406T3 (pl) Kompozycja
LT3558381T (lt) Skysta žmogaus fibrinogeno kompozicija
EP3405218A4 (en) DISINFECTING COMPOSITION